title: Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic management.
authors.forename: A
authors.initials: A
authors.lastname: Ulmer
authors.forename: F
authors.initials: F
authors.lastname: Wölbing
authors.forename: G
authors.initials: G
authors.lastname: Metzler
authors.forename: S
authors.initials: S
authors.lastname: Schanz
authors.forename: G
authors.initials: G
authors.lastname: Fierlbeck
authors.forename: M
authors.initials: M
authors.lastname: Röcken
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D002908:Chronic Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab